Effect of Botulinum Toxin Type A on a Rat Surgical Wound Model
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives. The tension on a wound is one of the important factors that determine the degree of fibrosis and scar formation. We hypothesized that local botulinum toxin type A (Botox) induced paralysis of the musculature subjacent to a surgical wound with a skin defect would minimize the repetitive tensile forces on the surgical wound’s edges, and this will result in a decreased fibroplastic response and fibrosis of the wound. Methods. This is a prospective randomized experimental study. Two distinct surgical wounds were made to the dorsum of 15 adult rats, respectively. One of the 2 wounds was injected with Botox, and the other wound was used as a control, and this was done for all the rats’ wounds. We evaluated the wound size, the degree of fibrosis and inflammation, the blood vessel proliferation, the thickness of the wound and the expression of transforming growth factor (TGF)-β1 in the wounds. Results. There were significant differences of wound size at the 3rd and 4th week between the Botox and control groups (P<0.05). The Botox group showed less infiltration of inflammatory cells than the control group at the 2nd week (P<0.05). The Botox group showed a smaller number of fibroblasts and less fibrosis than the control group at the 4th week (P<0.05). The Botox group showed much strong collagen density than the control group at the 8th week (P<0.05). For the immunohistochemical staining, there was a lower transforming growth factor (TGF)-β1 expression in the Botox group than that of the control group at the 4th week (P<0.05). Conclusion. The wounds of the Botox-treated group showed a larger wound size, less infiltration of inflammatory cells and less fibrosis, a much greater amount of collagen and a lower expression of TGF-β1 than did the control group. Botox might be used to decrease the fibrosis of a surgical wound without damaging the epithelial growth in situations for which decreased fibrosis is necessary, such as for treating laryngeal, tracheal and nasal stenosis.
Abstract
Objectives. The tension on a wound is one of the important factors that determine the degree of fibrosis and scar formation. We hypothesized that local botulinum toxin type A (Botox) induced paralysis of the musculature subjacent to a surgical wound with a skin defect would minimize the repetitive tensile forces on the surgical wound’s edges, and this will result in a decreased fibroplastic response and fibrosis of the wound. Methods. This is a prospective randomized experimental study. Two distinct surgical wounds were made to the dorsum of 15 adult rats, respectively. One of the 2 wounds was injected with Botox, and the other wound was used as a control, and this was done for all the rats’ wounds. We evaluated the wound size, the degree of fibrosis and inflammation, the blood vessel proliferation, the thickness of the wound and the expression of transforming growth factor (TGF)-β1 in the wounds. Results. There were significant differences of wound size at the 3rd and 4th week between the Botox and control groups (P<0.05). The Botox group showed less infiltration of inflammatory cells than the control group at the 2nd week (P<0.05). The Botox group showed a smaller number of fibroblasts and less fibrosis than the control group at the 4th week (P<0.05). The Botox group showed much strong collagen density than the control group at the 8th week (P<0.05). For the immunohistochemical staining, there was a lower transforming growth factor (TGF)-β1 expression in the Botox group than that of the control group at the 4th week (P<0.05). Conclusion. The wounds of the Botox-treated group showed a larger wound size, less infiltration of inflammatory cells and less fibrosis, a much greater amount of collagen and a lower expression of TGF-β1 than did the control group. Botox might be used to decrease the fibrosis of a surgical wound without damaging the epithelial growth in situations for which decreased fibrosis is necessary, such as for treating laryngeal, tracheal and nasal stenosis.
참고문헌 (21)
- Manuskiatti W, "Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments", Arch Dermatol, 138(9), pp.1149~1155 (2002)
- Fitzpatrick RE, "Treatment of inflamed hypertrophic scars using intralesional 5-FU", Dermatol Surg., 25(3), pp.224~232 (1999)
- Chowdri NA, "Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy", Aust N Z J Surg., 69(9), pp.655~659 (1999)
- Alster T, "Laser scar revision: comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids", Dermatol Surg, 29(1), pp.25~29 (2003)
- Crooke ST, "Mitomycin C: a review", Cancer Treat Rev., 3(3), pp.121~139 (1976)
- Miyamura S, "The biological studies on mitomycin I: antibacterial activities of mitomycin derivatives", J Antibiot, 20(2), pp.72~76 (1967)
- Hu D, "Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts", Ophthal Plast Reconstr Surg, 16(2), pp.119~125 (2000)
- Garrett CG, "Effect of mitomycin-C on vocal fold healing in a canine model", Ann Otol Rhinol Laryngol, 110(1), pp.25~30 (2001)
- De Bruijn EA, "Pharmacodynamics and pharmacokinetics of intravesical mitomycin C upon different dwelling times", Int J Cancer., 51(3), pp.359~364 (1992)
- Oboshi S, "Antitumor studies on mitomycin derivatives. II. Effec of solid tumor of sarcoma-180", Gann, 58(4), pp.315~321 (1967)
- Hueman EM, "Airway complications from topical mitomycin C", Otolaryngol Head Neck Surg, 133(6), pp.831~835 (2005)
- Sherris DA, "Management of scar contractures, hypertrophic scars, and keloids", Otolaryngol Clin North Am, 28(5), pp.1057~1068 (1995)
- Blitzer A, "Botulinum toxin: basic science and clinical uses in otolaryngology", Laryngoscope, 111(2), pp.218~226 (2001)
- Keir J, "Botulinum toxin-physiology and applications in head and neck disorders", Head Neck, 27(6), pp.525~535 (2005)
- Gassner HG, "Chemoimmobilization: improving predictability in the treatment of facial scars", Plast Reconstr Surg, 112(5), pp.1464~1466 (2003)
- Kantor J, "Efficacy and prognostic value of simple wound measurements", Arch Dermatol, 134(12), pp.1571~1574 (1998)
- Philips LG, "Wound healing. in: Textbook of surgery", pp.131~155 (2001), WB Saunders Co.
- Ribeiro Fde A, "Clinical and histological healing of surgical wounds treated with mitomycin C", Laryngoscope, 114(1), pp.148~152 (2004)
- Gassner HG, "Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates", Plast Reconstr S, 105(6), pp.1948~1953 (2000)
- Gassner HG, "Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study", Mayo Clin Proc., pp.1023~1028 (2006)
- Khera M, "Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures", J Urol., 172(2), pp.574~575 (2004)